[go: up one dir, main page]

AU2002313770A1 - Vascular endothelial growth factor 2 - Google Patents

Vascular endothelial growth factor 2

Info

Publication number
AU2002313770A1
AU2002313770A1 AU2002313770A AU2002313770A AU2002313770A1 AU 2002313770 A1 AU2002313770 A1 AU 2002313770A1 AU 2002313770 A AU2002313770 A AU 2002313770A AU 2002313770 A AU2002313770 A AU 2002313770A AU 2002313770 A1 AU2002313770 A1 AU 2002313770A1
Authority
AU
Australia
Prior art keywords
growth factor
vascular endothelial
endothelial growth
vascular
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002313770A
Inventor
Vivian R. Albert
Graig A. Rosen
Steven M. Ruben
Ruth E. Wager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/011474 external-priority patent/WO2002083704A1/en
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2002313770A1 publication Critical patent/AU2002313770A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002313770A 2002-04-12 2002-08-19 Vascular endothelial growth factor 2 Abandoned AU2002313770A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2002/011474 WO2002083704A1 (en) 2001-04-13 2002-04-12 Vascular endothelial growth factor 2
AUPCT/US2002/011474 2002-04-12
PCT/US2002/026246 WO2003097660A1 (en) 2002-04-12 2002-08-19 Vascular endothelial growth factor 2

Publications (1)

Publication Number Publication Date
AU2002313770A1 true AU2002313770A1 (en) 2003-12-02

Family

ID=29547634

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002313770A Abandoned AU2002313770A1 (en) 2002-04-12 2002-08-19 Vascular endothelial growth factor 2

Country Status (2)

Country Link
AU (1) AU2002313770A1 (en)
WO (1) WO2003097660A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7186688B1 (en) 1994-03-08 2007-03-06 Human Genome Sciences, Inc. Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
US5932540A (en) 1994-03-08 1999-08-03 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
CN1267550C (en) 1994-03-08 2006-08-02 人体基因组科学有限公司 Vascular endothelial growth factor 2
US6040157A (en) 1994-03-08 2000-03-21 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US6608182B1 (en) 1994-03-08 2003-08-19 Human Genome Sciences, Inc. Human vascular endothelial growth factor 2
US7153827B1 (en) 1994-03-08 2006-12-26 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 and methods of use
US7109308B1 (en) 1994-03-08 2006-09-19 Human Genome Sciences, Inc. Antibodies to human vascular endothelial growth factor 2
US7223724B1 (en) 1999-02-08 2007-05-29 Human Genome Sciences, Inc. Use of vascular endothelial growth factor to treat photoreceptor cells
KR20020059609A (en) 2000-08-04 2002-07-13 벤슨 로버트 에이치. Vascular endothelial growth factor 2
KR20030093316A (en) 2001-04-13 2003-12-06 휴먼 게놈 사이언시즈, 인코포레이티드 Vascular endothelial growth factor 2
AU2008219216A1 (en) * 2007-02-21 2008-08-28 Ablynx N.V. Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040157A (en) * 1994-03-08 2000-03-21 Human Genome Sciences, Inc. Vascular endothelial growth factor 2

Also Published As

Publication number Publication date
WO2003097660A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
AU2002252631A1 (en) Vascular endothelial growth factor 2
WO2002083850A8 (en) Vascular endothelial growth factor 2
EP1313512A4 (en) Vascular endothelial growth factor 2
AU5023300A (en) Vascular endothelial growth factor variants
AU2002227441A1 (en) Biocompatible adhesives
AU2002231182A1 (en) Surgical articles
AU2003272805A1 (en) Bioactive implants
AU2002342653A1 (en) Modified growth hormone
AU2002248304A1 (en) Vascular tissue composition
AUPR030900A0 (en) Growth factor complex
AU2002354966A1 (en) Stents
AU2002313770A1 (en) Vascular endothelial growth factor 2
AU2003216389A1 (en) Induction of hair growth with vascular endothelial growth factor
AU5026100A (en) Vascular endothelial growth factor dimers
AU2003266740A1 (en) Shelf construction
AU2003257651A1 (en) 4'-thionucleotide
AU5903600A (en) A novel vascular endothelial growth factor family member and uses thereof
AU2003220805A1 (en) Antiopoietin-related growth factor
AU2001277733A1 (en) Chimeric human-type vascular endothelial cell growth factor
HK1054513A (en) Vascular endothelial growth factor 2
HK1100133A (en) Inhibitors of type 2 vascular endothelial growth factor receptors
AU2003278629A1 (en) Mailbox
AU2003291871A1 (en) Bone growth factor
AU2003214263A1 (en) Showcase
AU2002343226A1 (en) Synthetic vascular prosthesis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase